Role of Vpr in HIV-1 nuclear Import: Therapeutic implications

Current HIV Research

Volumn 7, Issue 2, 2009, Pages 136-143

  Aida, Yoko ^a   Matsuda, Go ^a  

^a RIKEN   (Japan)

Author keywords

HIV 1Vpr; Importin ; Non dividing cells; Nuclear import; Nuclear pore complex (NPC); Nucleoporins; Pre integration complex (PIC)

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; FZ 41; ITI 367; KARYOPHERIN ALPHA; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRANSFER RNA; UNCLASSIFIED DRUG; VIRUS RNA; VPR PROTEIN; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; DRUG TARGETING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE FUNCTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PATIENT COMPLIANCE; PHARMACOLOGICAL BLOCKING; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; UNSPECIFIED SIDE EFFECT; VIRUS EXPRESSION; VIRUS REPLICATION; ACTIVE TRANSPORT; MACROPHAGE; PHYSIOLOGY; VIROLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTI-HIV AGENTS; HIV-1; HUMANS; MACROPHAGES; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 64749102559     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209787581418     Document Type: Review

References (107)

1. Fouchier RAM, Malim MH. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res 1999; 52: 275-99.
2. Greber UF, Fassati A. Nuclear import of viral DNA genomes. Traffic 2003; 4: 136-43.
3. Terry LJ, Shows EB, Wente SR. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 2007; 318: 1412-6.
4. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005; 6: 21-31.
5. Fahrenkrog B, Aebi U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat Rev Mol Cell Biol 2003; 4: 757-66.
6. Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J Cell Biol 2000; 148: 635-52.
7. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002; 158: 915-27.
8. Dworetzky SI, Feldherr CM. Translocation of RNA-coated gold particles through the nuclear pores of oocytes. J Cell Biol 1988; 106: 575-84.
9. Fried H, Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 2003; 60: 1659-88.
10. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol 2004; 14: 505-14.
11. Harel A, Forbes DJ. Importin beta: conducting a much larger cellular symphony. Mol Cell 2004; 16: 319-30.
12. Quimby BB, Dasso M. The small GTPase Ran: interpreting the signs. Curr Opin Cell Biol 2003; 15: 338-44.
13. Stewart M. Insights into the molecular mechanism of nuclear trafficking using nuclear transport factor 2 (NTF2). Cell Struct Funct 2000; 25: 217-25.
14. Herold A, Truant R, Wiegand H, Cullen BR. Determination of the functional domain organization of the importin alpha nuclear import factor. J Cell Biol 1998; 143: 309-18.
15. Kobe B. Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin α Nat Struct Biol 1999; 6: 388-97.
16. Harel J, Rassart E, Jolicoeur P. Cell cycle dependence of synthesis of unintegrated viral DNA inmouse cells newly infected with murine leukemia virus. Virology 1981; 110: 202-7.
17. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-42.
18. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-108.
19. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510-6.
20. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 1985; 82: 7086-90.
21. Weinberg JB, Matthews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of non-proliferating human monocytes. J Exp Med 1991; 174: 1477-82.
22. Bukrinsky MI, Sharova N, Dempsey MP, et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 1992; 89: 6580-4.
23. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11: 3053-8.
24. Cohen OJ, Fauci AS. Current strategies in the treatment of HIV infection. Adv Intern Med 2001; 46: 207-46.
25. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002; 53: 557-93.
26. McDonald D, Vodicka MA, Lucero G, et al. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002; 159: 441-52.
27. Arhel N, Genovesio A, Kim KA, et al. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods 2006; 3: 817-24.
28. Arhel NJ, Souquere-Besse S, Munier S, et al. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J 2007; 26: 3025-37.
29. Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol 2001; 75: 3626-35.
30. Yamashita M, Perez O, Hope TJ, Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 2007; 3: 1502-10.
31. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 1993; 90: 6125-9.
32. Gallay P, Swingler S, Aiken C, Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995; 80: 379-88.
33. Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997; 71: 5382-90.
34. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 2006; 3: 4.
35. Nermut MV, Fassati A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol 2003; 77: 8196-206.
36. Mirambeau G, Lyonnais S, Coulaud D, et al. HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner. PLoS ONE 2007; 2: e669.
37. Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 1998; 67: 265-306.
38. Panté N, Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol Biol Cell 2002; 13: 425-34.
39. Charneau P, Clavel F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol 1991; 65: 2415-21.
40. Gallay P, Hope T, Chin D, Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 1997; 94: 9825-30.
41. Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J 2003; 22: 3675-85.
42. Hearps AC, Jans DA. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta dependent mechanism. Biochem J 2006; 398: 475-84.
43. Popov S, Rexach M, Zybarth G, et al. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J 1998; 17: 909-17.
44. Vodicka MA, Koepp DM, Silver PA, Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 1998; 12: 175-85.
45. Kamata M, Nitahara-Kasahara Y, Miyamoto Y, Yoneda Y, Aida Y. Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr. J Virol 2005; 79: 3557-64.
46. Nitahara-Kasahara Y, Kamata M, Yamamoto T, et al. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. J Virol 2007; 81: 5284-93.
47. Jenkins Y, McEntee M, Weis K, Greene WC. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J Cell Biol 1998; 143: 875-85.
48. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol 1996; 70: 1027-32.
49. Haffar OK, Popov S, Dubrovsky L, et al. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol 2000; 299: 359-68.
50. Christ F, Thys W, De Rijck J, et al. Transportin-SR2 imports HIV into the nucleus. Curr Biol 2008; 18: 1192-202.
51. Zaitseva L, Myers R, Fassati A. tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes. PLoS Biol 2006; 4: e332.
52. Shaheen HH, Hopper AK. Retrograde movement of tRNAs from the cytoplasm to the nucleus in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2005; 102: 11290-5.
53. Takano A, Endo T, Yoshihisa T. tRNA actively shuttles between the nucleus and cytosol in yeast. Science 2005; 309: 140-2.
54. Bukrinsky M, Adzhubei A. Viral protein R of HIV-1. Rev Med Virol 1999; 9: 39-49.
55. Rouzic EL, Benichou S. The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2005; 2: 11.
56. Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology 2006; 3: 74.
57. Zhao RY, Elder RT, Bukrinsky M. Interactions of HIV-1 viral protein R with host cell proteins. Adv Pharmacol 2007; 55: 233-60.
58. Cohen EA, Dehni G, Sodroski JG, Haseltine WA. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 1990; 64: 3097-9.
59. Lu YL, Spearman P, Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 1993; 67: 6542-50.
60. Heinzinger NK, Bukinsky MI, Haggerty SA, et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994; 91: 7311-5.
61. Bukrinsky MI, Haggerty S, Dempsey MP, et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666-9.
62. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206: 935-44.
63. Fouchier RA, Meyer BE, Simon JH, et al. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol 1998; 72: 6004-13.
64. Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J Biol Chem 1998; 273: 13347-52.
65. Le Rouzic E, Mousnier A, Rustum C, et al. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J Biol Chem 2002; 277: 45091-8.
66. Balliet JW, Kolson DL, Eiger G, et al. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 1994; 200: 623-31.
67. Iijima S, Nitahara-Kasahara Y, Kimata K, et al. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells. Virology 2004; 327: 249-61.
68. Kootstra NA, Schuitemaker H. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wildtype HIV-1 in primary macrophages. Virology 1999; 253: 170-80.
69. Bouyac-Bertoia M, Dvorin JD, Fouchier RAM, et al. HIV-1 infection requires a functional integrase NLS. Mol Cell 2001; 7: 1025-35.
70. Yamashita M, Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 2005; 1: e18.
71. Gallay P, Swingler S, Song J, Bushman F, Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995; 83: 569-76.
72. Mahalingam S, Collman RG, Patel M, Monken CE, Srinivasan A. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology 1995; 212: 331-9.
73. Aitchison JD, Blobel G, Rout MP. Kap104p: a karyopherin involved in the nuclear transport of messenger RNA binding proteins. Science 1996; 274: 624-27.
74. Pollard VW, Michael WM, Nakielny S, Siomi MC, Wang F, Dreyfuss G. A novel receptor-mediated nuclear protein import pathway. Cell 1996; 86: 985-94.
75. Bischoff FR, Klebe C, Kretschmer J, Wittinghofer A, Ponstingl H. RanGAP1 induces GTPase activity of nuclear Ras-related Ran. Proc Natl Acad Sci USA 1994; 91: 2587-91.
76. Nakielny S, Siomi MC, Siomi H, Michael WM, Pollard V, Dreyfuss G. Transportin: nuclear transport receptor of a novel nuclear protein import pathway. Exp Cell Res 1996; 229: 261-6.
77. Morellet N, Bouaziz S, Petitjean P, Roques BP. NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol 2003; 327: 215-27.
78. Kamata M, Aida Y. Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms. J Virol 2000; 74: 7179-86.
79. Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Weiner DB. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol 1997; 71: 6339-47.
80. Yao XJ, Subbramanian RA, Rougeau N, Boisvert F, Bergeron D, Cohen EA. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol 1995; 69: 7032-44.
81. Zhou Y, Lu Y, Ratner L. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest. Virology 1998; 242: 414-24.
82. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1Vpr. J Virol 1995; 69: 7909-16.
83. Karni O, Friedler A, Zakai N, Gilon C, Loyter A. A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr. FEBS Lett 1998; 429: 421-5.
84. Depienne C, Roques P, Creminon C, et al. Cellular Distribution and Karyophilic Properties of Matrix, Integrase, and Vpr Proteins from the Human and Simian Immunodeficiency Viruses. Exp Cell Res 2000; 260: 387-95.
85. Rout MP, Aitchison JD. The nuclear pore complex as a transport machine. J Biol Chem 2001; 276: 16593-6.
86. Jacquot G, Le Rouzic E, David A, et al. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007; 4: 84.
87. de Noronha CMC, Sherman MP, Lin HW, et al. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 2001; 294: 1105-8.
88. Segura-Totten M, Wilson KL. Virology: HIV-breaking the rules for nuclear entry. Science 2001; 294: 1016-7.
89. Scott ES, O'Hare P. Fate of the inner nuclear membrane protein lamin B receptor and nuclear lamins in herpes simplex virus type 1 infection. J Virol 2001; 75: 8818-30.
90. Kotera I, Sekimoto T, Miyamoto Y, et al. Importin alpha transports CaMKIV to the nucleus without utilizing importin beta. EMBO J 2005; 24: 942-51.
91. Agostini I, Popov S, Li J, Dubrovsky L, Hao T, Bukrinsky M. Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp Cell Res 2000; 259: 398-403.
92. Ghorpade A, Xia MQ, Hyman BT, et al. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol 1998; 72: 3351-61.
93. Neil S, Martin F, Ikeda Y, Collins M. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol 2001; 75: 5448-56.
94. Barbaro G, Scozzafava A, Mastrolorenzo A, Supuran CT. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des 2005; 11: 1805-43.
95. Deeks SG. Antiretroviral treatment of HIV infected adults. BMJ 2006; 332: 1489.
96. Kijak GH, Currier JR, Tovanabutra S, et al. Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance. AIDS Rev 2004; 6: 54-60.
97. Siliciano JD, Siliciano RF. Latency and viral persistence in HIV-1 infection. J Clin Invest 2000; 106: 823-5.
98. Saksena NK, Potter SJ. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. AIDS Rev 2003; 5: 3-18.
99. Kulkosky J, Bray S. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr HIV Res 2006; 4: 199-208.
100. Back DJ, Khoo SH, Maher B, Gibbons SE. Current uses and future hopes for clinical pharmacology in the management of HIV infection. HIV Med 2000; 2: 12-7.
101. Montessori V, Press N, Harris M, Akagi L, Montaner JS. Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc J 2004; 170: 229-38.
102. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997; 276: 1857-61.
103. Orenstein JM, Feinberg M, Yoder C, et al. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS 1999; 13: 2219-29.
104. Suzuki T, Yamamoto N, Nonaka M, et al. Inhibition of human immunodeficiency Virus Type 1 (HIV-1) Nuclear Import via Vpr-Importin α Interactions as a Novel HIV-1 Therapy. Biochem Biophys Res Commun (In press).
105. Bonnenfant S, Thomas CM, Vita C, et al. Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents. J Virol 2004; 78: 5728-36.
106. Mousnier A, Leh H, Mouscadet JF, Dargemont C. Nuclear import of HIV-1 integrase is inhibited in vitro by styrylquinoline derivatives. Mol Pharmacol 2004; 66: 783-8.
107. Haffar O, Dubrovsky L, Lowe R, et al. Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. J Virol 2005; 79: 13028-36.